Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.
COVID-19
inflammatory markers
mortality
prognosis
sex hormones
Journal
Andrology
ISSN: 2047-2927
Titre abrégé: Andrology
Pays: England
ID NLM: 101585129
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
11
05
2020
revised:
12
05
2020
accepted:
13
05
2020
pubmed:
22
5
2020
medline:
4
2
2021
entrez:
22
5
2020
Statut:
ppublish
Résumé
The pandemic of new severe acute respiratory syndrome (SARS) due to coronavirus (CoV) 2 (SARS-CoV-2) has stressed the importance of effective diagnostic and prognostic biomarkers of clinical worsening and mortality. Epidemiological data showing a differential impact of SARS-CoV-2 infection on women and men have suggested a potential role for testosterone (T) in determining gender disparity in the SARS-CoV-2 clinical outcomes. To estimate the association between T level and SARS-CoV-2 clinical outcomes (defined as conditions requiring transfer to higher or lower intensity of care or death) in a cohort of patients admitted in the respiratory intensive care unit (RICU). A consecutive series of 31 male patients affected by SARS-CoV-2 pneumonia and recovered in the respiratory intensive care unit (RICU) of the "Carlo Poma" Hospital in Mantua were analyzed. Several biochemical risk factors (ie, blood count and leukocyte formula, C-reactive protein (CRP), procalcitonin (PCT), lactate dehydrogenase (LDH), ferritin, D-dimer, fibrinogen, interleukin 6 (IL-6)) as well as total testosterone (TT), calculated free T (cFT), sex hormone-binding globulin (SHBG), and luteinizing hormone (LH) were determined. Lower TT and cFT were found in the transferred to ICU/deceased in RICU group vs groups of patients transferred to IM or maintained in the RICU in stable condition. Both TT and cFT showed a negative significant correlation with biochemical risk factors (ie, the neutrophil count, LDH, and PCT) but a positive association with the lymphocyte count. Likewise, TT was also negatively associated with CRP and ferritin levels. A steep increase in both ICU transfer and mortality risk was observed in men with TT < 5 nmol/L or cFT < 100 pmol/L. Our study demonstrates for the first time that lower baseline levels of TT and cFT levels predict poor prognosis and mortality in SARS-CoV-2-infected men admitted to RICU.
Sections du résumé
BACKGROUND
The pandemic of new severe acute respiratory syndrome (SARS) due to coronavirus (CoV) 2 (SARS-CoV-2) has stressed the importance of effective diagnostic and prognostic biomarkers of clinical worsening and mortality. Epidemiological data showing a differential impact of SARS-CoV-2 infection on women and men have suggested a potential role for testosterone (T) in determining gender disparity in the SARS-CoV-2 clinical outcomes.
OBJECTIVES
To estimate the association between T level and SARS-CoV-2 clinical outcomes (defined as conditions requiring transfer to higher or lower intensity of care or death) in a cohort of patients admitted in the respiratory intensive care unit (RICU).
MATERIALS AND METHODS
A consecutive series of 31 male patients affected by SARS-CoV-2 pneumonia and recovered in the respiratory intensive care unit (RICU) of the "Carlo Poma" Hospital in Mantua were analyzed. Several biochemical risk factors (ie, blood count and leukocyte formula, C-reactive protein (CRP), procalcitonin (PCT), lactate dehydrogenase (LDH), ferritin, D-dimer, fibrinogen, interleukin 6 (IL-6)) as well as total testosterone (TT), calculated free T (cFT), sex hormone-binding globulin (SHBG), and luteinizing hormone (LH) were determined.
RESULTS
Lower TT and cFT were found in the transferred to ICU/deceased in RICU group vs groups of patients transferred to IM or maintained in the RICU in stable condition. Both TT and cFT showed a negative significant correlation with biochemical risk factors (ie, the neutrophil count, LDH, and PCT) but a positive association with the lymphocyte count. Likewise, TT was also negatively associated with CRP and ferritin levels. A steep increase in both ICU transfer and mortality risk was observed in men with TT < 5 nmol/L or cFT < 100 pmol/L.
DISCUSSION AND CONCLUSION
Our study demonstrates for the first time that lower baseline levels of TT and cFT levels predict poor prognosis and mortality in SARS-CoV-2-infected men admitted to RICU.
Identifiants
pubmed: 32436355
doi: 10.1111/andr.12821
pmc: PMC7280645
doi:
Substances chimiques
Biomarkers
0
Testosterone
3XMK78S47O
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
88-98Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 American Society of Andrology and European Academy of Andrology.
Références
J Steroid Biochem. 1987;27(1-3):343-50
pubmed: 2826891
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128
pubmed: 32146445
Kidney Int Rep. 2017 Aug 04;2(6):1160-1168
pubmed: 29270524
J Endocrinol. 2012 Jan;212(1):71-84
pubmed: 22010203
J Sex Med. 2018 Sep;15(9):1260-1271
pubmed: 30145097
Aging Cell. 2020 Jul;19(7):
pubmed: 32558150
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
J Clin Endocrinol Metab. 2011 Oct;96(10):3007-19
pubmed: 21816776
J Immunol. 2001 Aug 15;167(4):2060-7
pubmed: 11489988
J Med Virol. 2020 Oct;92(10):1733-1734
pubmed: 32242950
J Clin Endocrinol Metab. 2007 Nov;92(11):4241-7
pubmed: 17698901
Metabolism. 2020 Jul;108:154252
pubmed: 32353355
Cells. 2020 Apr 09;9(4):
pubmed: 32283711
J Endocrinol. 2013 Apr 29;217(3):R25-45
pubmed: 23378050
Endocrinology. 2004 Oct;145(10):4703-11
pubmed: 15231706
Diabetes Metab Res Rev. 2020 Mar 31;:e3319
pubmed: 32233013
J Clin Endocrinol Metab. 2008 Jul;93(7):2737-45
pubmed: 18270261
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Endocrinol. 2012 Jul;214(1):31-43
pubmed: 22562653
J Clin Endocrinol Metab. 2010 Apr;95(4):1810-8
pubmed: 20173018
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
N Engl J Med. 2020 Jun 18;382(25):e102
pubmed: 32356626
Int J Endocrinol. 2014;2014:858715
pubmed: 24976827
J Biol Chem. 1988 Apr 15;263(11):5070-4
pubmed: 2833494
Aging Male. 2019 Jun;22(2):129-140
pubmed: 29925283
J Endocrinol. 1986 Jun;109(3):419-25
pubmed: 3525730
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
Andrology. 2021 Jan;9(1):19-22
pubmed: 32369678
J Immunol. 2011 May 1;186(9):5162-72
pubmed: 21441459
Andrology. 2020 Sep;8(5):970-987
pubmed: 32026626
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Andrology. 2021 Jan;9(1):88-98
pubmed: 32436355
Prostate. 2013 Jun;73(8):789-800
pubmed: 23620238
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
pubmed: 10523012
J Autoimmun. 2020 Aug;112:102463
pubmed: 32303424
J Endocrinol Invest. 2014 Feb;37(2):135-41
pubmed: 24497212
Biol Reprod. 2006 Feb;74(2):410-6
pubmed: 16237152
Metabolism. 2018 Sep;86:61-68
pubmed: 29656047